Trexquant Investment’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
115,681
-124,691
-52% -$1.19M 0.01% 1432
2026
Q1
$2.19M Buy
240,372
+108,524
+82% +$910K 0.02% 959
2025
Q4
$981K Buy
131,848
+105,365
+398% +$757K 0.01% 1186
2025
Q3
$177K Buy
+26,483
New +$184K ﹤0.01% 1510
2025
Q1
Sell
-44,471
Closed -$467K 1567
2024
Q4
$467K Sell
44,471
-58,493
-57% -$692K 0.01% 1297
2024
Q3
$1.23M Buy
+102,964
New +$890K 0.02% 977

Other funds holding BVS

Trexquant Investment's BVS Position: Q2 2026 in Review

Trexquant Investment reduced its Bioventus (BVS) stake by 52% in Q2 2026, selling an estimated $1.19M and leaving 115,681 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #1432.

Trexquant Investment first reported a position in BVS in Q3 2024 and has held it in 6 quarters since. The position peaked at $2.19M in Q1 2026. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Trexquant Investment held 115,681 shares of Bioventus worth $1.09M as of Q2 2026.
  • Trexquant Investment sold 124,691 Bioventus shares in Q2 2026, an estimated $1.19M.
  • Bioventus made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1432 holding.
  • Trexquant Investment first reported a position in Bioventus in Q3 2024 and has held it in 6 quarters since.
  • Trexquant Investment's Bioventus position peaked at $2.19M in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.